Core Viewpoint - The "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" aims to enhance the efficiency, quality, and innovation capabilities of the pharmaceutical industry through digital transformation and the application of technologies like artificial intelligence [1][2]. Group 1: Transformation Goals - By 2027, the plan targets breakthroughs in key technologies, the establishment of over 30 technical standards, and the development of more than 100 high-performance products in smart pharmaceutical equipment and software [2]. - The plan aims for full coverage of digital transformation among large-scale pharmaceutical enterprises by 2030 [2]. Group 2: Key Actions - The plan outlines four main action areas: empowering with digital technology, promoting digital transformation, building a supportive service system, and enhancing regulatory capabilities [3][4][5][6]. - Specific tasks include developing exemplary application scenarios, fostering leading enterprises, and establishing innovation platforms [2][6]. Group 3: Industry Impact - The digital transformation is expected to accelerate the entire pharmaceutical supply chain, improving collaboration and operational efficiency from raw material suppliers to healthcare institutions [7]. - AI-driven platforms are anticipated to significantly reduce drug development cycles and costs, facilitating faster market entry for new drugs [8][10]. Group 4: Traditional Medicine Modernization - The digital transformation will also support the modernization and internationalization of traditional Chinese medicine, enhancing its quality and consistency through automated production processes [8][10]. - AI technologies are being utilized to optimize traditional medicine formulations and predict new indications, thereby streamlining the research and development process [8][10].